+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Dermatology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
From
From
RNA Interference Therapy-Competitive landscape, 2023 - Product Thumbnail Image

RNA Interference Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
From
Immunomodulators - Global Strategic Business Report - Product Thumbnail Image

Immunomodulators - Global Strategic Business Report

  • Report
  • October 2025
  • 280 Pages
  • Global
From
From
Hodgkins Lymphoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Hodgkins Lymphoma Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 127 Pages
  • Global
From
Loading Indicator